BioLargo Revenue, Profits - BLGO Annual Income Statement

Add to My Stocks
$0.29 $0.01 (3.33%) BLGO stock closing price Aug 13, 2018 (Closing)

Fundamental analysis of BLGO stock involves analyzing its financial statements, apart from checking the BioLargo stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2017 impacts the BLGO stock. Investors typically check year over year or quarter over quarter revenue growth. The operating expenses as shown in the BioLargo profit and loss statement for 2017 total to $6.04M. This line item shows that the operating expenses has increased compared with last year. Also check: BioLargo assets and BioLargo free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
BioLargo Revenues or Net Sales
----------
Cost Of Goods Sold (COGS)----------
BioLargo Gross Profit
----------
Research & Development Expense1.62M1.38M--------
Selling General & Admin Expense4.42M3.71M3.55M2.79M2M4.61M3.16M4.11M3.96M4.82M
Income Before Depreciation Depletion Amortization-5.86M-4.92M-4.17M-3.38M-2.6M-4.71M-3.15M-4.18M-4.1M-4.94M
Depreciation Depletion Amortization--------9.89M1.1M
Non Operating Income--0.01M--------
Interest Expense3.86M3.12M-----1.66M1.62M1.14M
BioLargo Pretax Income
-9.54M-8.07M-5.07M-3.73M-2.9M-5.33M-3.95M-5.74M-15.61M-7.14M
Provision for Income Taxes----------
MinorityInterest-0.42M-0.23M-0.02M-0.04M-0.37M-----
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-9.54M-8.07M-5.07M-3.73M-2.9M-5.33M-3.95M-5.74M-15.61M-7.14M
Extraordinary Items & Discontinued Operations----------
BioLargo Profit/ Loss (Net Income)
-9.11M-7.83M-5.05M-3.69M-2.52M-5.33M-3.95M-5.74M-15.61M-7.14M
Average Shares used to compute Diluted EPS98.94M87.94M84.11M80.02M72.95M63.75M----
Average Shares used to compute Basic EPS98.94M87.94M84.11M80.02M72.95M63.75M----
Income Before Nonrecurring Items-9.12M-7.84M-5.06M-3.69M-2.53M-5.33M----
Income from Nonrecurring Items----------
BioLargo Earnings Per Share Basic Net
-0.10-0.09-0.06-0.05-0.04-0.08-0.07-0.13-0.37-0.18
BioLargo Earnings Per Share Diluted Net
-0.10-0.09-0.06-0.05-0.04-0.08----
EPS Diluted Before Nonrecurring Items-0.10-0.09-0.06-0.05-0.04-0.08----
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on BioLargo stock analysis. It helps to look at the following income statement items:

  • Topline: A growing topline, as seen from the BioLargo revenue chart, as isn't the case with BioLargo indicates a sagging business. One needs to compare the YoY topline or sales growth of BLGO stock with its peers like MCEP stock and WHZT stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. BLGO stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the BLGO income statement, one can check the BioLargo historical stock prices to check how the price has moved with time.

BioLargo Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
40.88
Dividend Yield
0%